Factor VII deficiency caused by a structural variant N57D of the first epidermal growth factor domain.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Blood

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD.V91.1.142.142_142_148PMID 9414278
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Factor VII gene polymorphisms contribute about one third of the factor VII level variation in plasma.

  1996cited by this paper
• A Thr359Met mutation in factor VII of a patient with a hereditary deficiency causes defective secretion of the molecule.

  1996cited by this paper
• The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor

  1996cited by this paper
• Incomplete gamma carboxylation of human coagulation factor VII: differential effects on tissue factor binding and enzymatic activity

  1996cited by this paper
• Activation of a recombinant human factor VII structural analogue alters its affinity of binding to tissue factor

  1996cited by this paper
• Ultrarapid mutation detection by multiplex, solid-phase chemical cleavage.

  1995cited by this paper
• X-ray structure of clotting factor IXa: active site and module structure related to Xase activity and hemophilia B.

  1995cited by this paper
• Inherited Factor VII Deficiency: Genetics and Molecular Pathology

  1995cited by this paper
• The structure of a Ca(2+)-binding epidermal growth factor-like domain: its role in protein-protein interactions.

  1995cited by this paper
• Factor VII Antigen Levels in a Healthy Blood Donor Population

  1994cited by this paper
• Severe factor VII deficiency caused by mutations abolishing the cleavage site for activation and altering binding to tissue factor.

  1994cited by this paper
• Surface plasmon resonance studies of the interaction between factor VII and tissue factor. Demonstration of defective tissue factor binding in a variant FVII molecule (FVII-R79Q).

  1994cited by this paper
• Factor VII Mie: Homozygous Asymptomatic Type I Deficiency Caused by an Amino Acid Substitution of His (CAC) for Arg(247) (CGC) in the Catalytic Domain

  1994cited by this paper
• Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation.

  1993cited by this paper
• Epidermal growth factor-like modules

  1993cited by this paper
• Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation

  1993cited by this paper
• The direct binding of human factor VII in plasma to recombinant human tissue factor.

  1993cited by this paper
• A novel congenital haemostatic defect: combined factor VII and factor XI deficiency

  1992cited by this paper
• Human epidermal growth factor

  1992cited by this paper
• Site-directed mutagenesis of virtually any plasmid by eliminating a unique site.

  1992cited by this paper
• The first epidermal growth factor domain of human coagulation factor VII is essential for binding with tissue factor

  1992cited by this paper
• Human epidermal growth factor. High resolution solution structure and comparison with human transforming growth factor alpha.

  1992cited by this paper
• Molecular cloning and expression of rabbit antithrombin III.

  1992cited by this paper
• The low molecular weight heparin Enoxaparin inhibits the consumption of factor VII and prothrombin activation in vivo associated with elective knee replacement surgery

  1992cited by this paper
• Structure-function relationships of epidermal growth factor modules in vitamin K-dependent clotting factors.

  1991cited by this paper
• Identification of molecular sites on factor VII which mediate its assembly and function in the extrinsic pathway activation complex.

  1991cited by this paper
• Localization of the human tissue factor recognition determinant of human factor VIIa.

  1991cited by this paper
• Purification and characterization of factor VII 304-Gln: a variant molecule with reduced activity isolated from a clinically unaffected male.

  1991cited by this paper
• Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody.

  1990cited by this paper
• The importance of residues 195-206 of human blood clotting factor VII in the interaction of factor VII with tissue factor.

  1990cited by this paper
• Cloning, structure, and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme.

  1989cited by this paper
• Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis.

  1989cited by this paper
• Protein oligomerization in the endoplasmic reticulum.

  1989cited by this paper
• Transport of secretory and membrane glycoproteins from the rough endoplasmic reticulum to the Golgi. A rate-limiting step in protein maturation and secretion.

  1988cited by this paper
• Structure and function of epidermal growth factor‐like regions in proteins

  1988cited by this paper
• Activation of factor VII bound to tissue factor: a key early step in the tissue factor pathway of blood coagulation.

  1988cited by this paper
• Regulation of protein export from the endoplasmic reticulum.

  1988cited by this paper
• Nucleotide sequence of the gene coding for human factor VII, a vitamin K-dependent protein participating in blood coagulation.

  1987cited by this paper
• Monoclonal anti-human factor VII antibodies. Detection in plasma of a second protein antigenically and genetically related to factor VII.

  1985cited by this paper
• "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum.

  1984cited by this paper
• Evidence that activities of coagulation factors VII and X are linked to chromosome 13 (q34).

  1984cited by this paper
• Cultured human endothelial cells generate tissue factor in response to endotoxin.

  1983cited by this paper
• A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

  1983cited by this paper
• The dual role of factor VII in blood coagulation. Initiation and inhibition of a proteolytic system by a zymogen.

  1982cited by this paper
• Coupled amidolytic assay for factor VII: its use with a clotting assay to determine the activity state of factor VII.

  1978cited by this paper

• Analysis of clinical manifestations and molecular pathogenesis of six patients with hereditary blood coagulation factor VII deficiency.

  2025cites this paper
• Hereditary coagulation factor VII deficiency caused by novel compound heterozygous mutations in a Chinese pedigree: A case report

  2022cites this paper
• Identification of two novel mutations in three children with congenital factor VII deficiency

  2021cites this paper
• A clinical-pathogenetic approach on associated anomalies and chromosomal defects supports novel candidate critical regions and genes for gastroschisis

  2018cites this paper
• Biological functions of fucose in mammals.

  2017cites this paper
• The significance of published polymorphisms in 14 cases of mild factor VII deficiency

  2005cites this paper
• Interspecies exchange mutagenesis of the first epidermal growth factor‐like domain of human factor VII

  2003cites this paper
• Two Naturally Occurring Mutations on FVII Gene (S363I-W364C) Altering Intrinsic Catalytic Activity

  2002cites this paper
• Analysis of the genotypes and phenotypes of 37 unrelated patients with inherited factor VII deficiency

  2001cites this paper
• Factor VII deficiency and the FVII mutation database

  2001cites this paper
• Activation and Active Site Occupation Alter Conformation in the Region of the First Epidermal Growth Factor-like Domain of Human Factor VII*

  2000cites this paper
• Molecular characterization of four novel mutations causing factor VII deficiency.

  2000cites this paper
• Linear analogues derived from the first EGF‐like domain of human blood coagulation factor VII: enhanced inhibition of FVIIa/TF complex activity by backbone modification through aspartimide formation

  1999cites this paper
• Probing the structural changes in the light chain of human coagulation factor VIIa due to tissue factor association.

  1999cites this paper
• Solution structure of the N-terminal EGF-like domain from human factor VII.

  1998cites this paper
• Coagulation Factor VII Gln100 → Arg

  1998cites this paper